Education
2007
- Board re-certification in pediatrics granted by the American College of Osteopathic Pediatricians after successfully completing the board recertification exam
1999
- Board Certification in Pediatrics granted by the American College of Osteopathic Pediatricians after successfully completing the pediatric board examination
1996-1999
- Internship/Residency
Completed an American Osteopathic Association approved pediatric emphasis internship and pediatric residency at Tulsa Regional Medical Center. Publishable research papers were submitted on The Indications for Tonsillectomy in the Pediatric Patient as an intern, and Sinusitis in the Pediatric Population as a senior resident.
1997-1999
- Instructor for Pediatric Advanced Life Support and Neonatal Advanced Life Support.
1993-1996
- D.O. (Doctor of Osteopathic Medicine)
OSU College of Osteopathic Medicine, Tulsa, OK
Employment
January 2009
- Named full-time Vice Chair of OSU CHS department of pediatrics
September 2006
- Interim Vice-chair, Department of Pediatrics and Clinic Manager
Oklahoma State University Center for Health Sciences, Tulsa, OK
February 2003-present
- Assistant Professor of Pediatrics
Oklahoma State University Center for Health Sciences
Duties include pediatric training of medical students, interns and residents, as well as direct patient care, minor procedures including circumcision and laceration repair and hospital rounds. Duties also include lecturing, case preparation and presentation, research and publishing.
2000-2003
- Clinical Associate Professor
Oklahoma State University College of Osteopathic Medicine
and Oklahoma University College of Medicine
- I instructed group sessions of manual medicine for the second year students of OSU COM 4 hours weekly. I also took students, interns and residents in my office for preceptorship training including core pediatric rotation for OSU COM medical students.
July 2003-February 2003
- Provided temporary contract medical services to Aventis Bioservices working nights and weekends as a clinic physician.
1999-2003
- Private practice Pediatrics - Springer Clinic Pediatric Urgent Care (20-40 hrs. per month)
Professional Affiliations
Fellow of the American College of Osteopathic Pediatricianssince 1999
Member of the American Osteopathic Association since 1996
Member of the Oklahoma Osteopathic Association. since 1996
Member of the Tulsa Osteopathic Medical Society since 1996
Staff privileges at the Oklahoma State University Medical Center,
Saint Francis Hospital, and courtesy privileges at Southcrest Medical Center, and Hillcrest Medical Center
Committees and Professional Services
May 2004 – present: Chairman of the Department of Pediatrics at OSUMC
Fall 2004: Served as chair of the search committee for Chairman of
the Department of Obstetrics and Gynecology
2004: Presented with the National Leadership Award by the National
Republican Congressional Committee by Congressman Tom DeLay,
Majority Whip
January 2005: Served on Academic Appeals Committee for OSU CHS
January 2005 –2007: Appointed to OSU Institutional Review Board, currently serving as alternate member
2005 – present: Appointed to Quality Utilization Council for OSUMC
2005 –present: Appointed Chair of the Women’s and Children’s Service Line of Tulsa Regional Medical Center
2005 –2006: Appointed Medical Advisor of the Tulsa Area Immunization Coalition
June 2005 –2006: Appointed to the Public Awareness Committee of the Oklahoma Osteopathic Association
July 2005-June 2007: Served as member of OSU CHS Academic Affairs Committee
February 2006-January 2007: Served on the Champion of Electronic Medical Records Committee to implement and train EMR in the medical clinics and pediatric department
September 2006: Named Interim Vice-Chair and Clinic Manager of OSU Department of Pediatrics
July 2007- present: Elected to 3 year term as CHS Faculty Council
Representative for Oklahoma State University
September 2007- present: Appointed to Academic Standards and Procedures Committee for Oklahoma State University, Stillwater
July 2007- present: Member of OSU CHS Faculty Senate
January 2008: Authored a Policy on Incomplete Grades for OSU,
Stillwater which was recommended by Faculty Council and approved
by the Provost
March 2008: Appointed to Faculty Council sub-committee for review of the university policy on external activities. Recommendations were made and presented to Faculty Council for recommendation to the Provost.
April 2008-October 2008: Served on selection committee to select new electronic medical records system for OSU CHS clinic systems.
May 2008: Served as chair of the search committee for chairman of the Department of Obstetrics and Gynecology
January 2009: Appointed full time vice-chair of the OSU CHS department of Pediatrics
Teaching and Educational Activities
October 1999 – February 2002: Spent 4 hours weekly in OMM lab providing hands-on instruction including didactics to 1st and 2nd year
medical students
February 2003 – present: Service as fulltime pediatric attending
physician for 3rd and 4th year medical students, interns, and residents in
hospital and out-patient clinic
February 2003: Presented 1 hour lecture to staff and medical students
with Powerpoint presentation titled Asthma in the Pediatric Patient
September 2003: Attended Osteopathic Medical Education
Conference on Competency-based curriculum
November 2004: Presented 3 hour lecture series with powerpoint and
discussion to the OSU Family Medicine Residents for their Academic
Afternoon titled Respiratory Illnesses in the Pediatric Patient
2004: Authored a protocol for sedation analgesia for pediatric patients at OSUMC
2003 – present: Service as preceptor for resident journal club and
Academic Afternoon on a rotating basis
2004: Co-authored a series of pediatric case-presentations with corresponding discussion topics and questions for birth to adolescence including developmental milestones, physical exam, disease process and associated physical findings, pertinent labs and testing including normal and abnormal findings for the Health Promotion/Disease Prevention Class at OSU CHS.
2005 - 2007: Presented a 3 hour lecture series to the 2nd year
medical students at OSU-CHS on Pediatric Well Child Visit and, Developmental Milestones
2007: Presented a 1 hour presentation to the OSU family medicine
Residents on Current Immunization Recommendations
February 2008: Assisted my department chair in the implementation of a teaching service as well as a private admitting service at Saint Francis Children’s hospital. This has provided better continuity of care for our patients and has enhanced the residency training program by providing the required volume and accuity for resident board eligibility
Publications and Speaking Engagements
1999: Authored a case study included in an article published by one of my
associates in the JAOA on Sinusitis in the Pediatric Patient
May 2003: Interview published in the Tulsa World on “Healthy Breakfast For Children”
September 2003: Invited to speak to the Gifted and Talented Class
for Bixby High School. The subject of the 1 hour long lecture
was Education for Success, and included audience interaction
August 2004: Guest speaker by request for The Tulsa Area Chapter of Play Therapists. The 1 hour lecture with powerpoint presentation was entitled ADHD Medication in the Pediatric Patient
September 2004: Interview published in The Tulsa World on Respiratory
Syncycial Virus Bronchiolitis
January 2005: Authored and filmed a news article on Respiratory Syncycial Virus for Medical Minute with Denise Brewer, anchorwoman, with channel 8 which aired on several segments of the channel 8 news .
May 2005: Authored and filmed a news article on tick-borne illness in Oklahoma for Medical Minute with Denise Brewer, anchorwoman, with channel 8 which aired on several segments of the Channel 8 News
September 2005: Presented a lecture series on immunizations to the School Nurses Organization of Oklahoma for the Tulsa Area Immunization Coalition
May 2006: Filmed interview and presentation on Morgellons Disease by Primetime Live which was aired in September 2006
September 2006: Filmed interview and presentation on Morgellons Disease for Dateline which aired in the same month
March 2007: Interview on Morgellons was published in Psychology Today
July 2007: Filmed interview and presentation on Morgellons
Disease for Dallas local news which aired the same month
October 2007: Interviewed by The Tulsa World on the voluntary recall of
over-the-counter pediatric cough medications
2007: Co-authored an abstract on Morgellons Disease which was published and presented at the2007 Molecular Medicine Tri-Conference in San Francisco
April 2008: Interviewed by The Tulsa World for Earth Day article on
cloth versus disposable diapers. This article was picked up and aired by CNN
July 2008: Interviewed on Channel 6 Morning News for Alzheimer’s fundraiser
Research
Subinvestigator for Safety and Efficacy of Pentavalent Human-Bovine Rotavirus Vaccine in Healthy Infants
Subinvestigator for A Comparison of the Safety, Tolerability, and Immunogenicity of M-M-R II Manufactured from the 2003 Measles Stock Seeds with Recombinant Human Albumin versus Currently Licensed M-M-R II Manufactured from the 1967 Measles Stock Seeds with Human Serum Albumin In Healthy Children 12 to 18 Months of Age
Subinvestigator for Study of Environmental Safety Education in the Pediatric Population. – an AAP Study
Subinvestigator for Safety & Immunogenicity of Fluzone Influenza Virus Vaccine (2005-2006 Formulation) Among Healthy Children 6 to 12 Weeks of Age
Subinvesigatorfor Efficacy of Combination Hib-MenCYTT009 & 010: A Phase III Randomized, Multinational Study, Double-Blinded for Immunogenicity and Consistency Evaluation of 3 Hib-MenCY-TT Vaccine Lots and Single-Blinded and Controlled for the Evaluation of Safety and Immunogenicity of GSK Biologicals’ Haemophilus influenzae type b and Neisseria meningitis Serogroups C and Y-Tetanus Toxoid Conjugate Vaccine Combined (Hib-MenCY-TT) Compared to Monovalent Hib Vaccine in Healthy Infants at 2, 4, 6, and 12-15 Months of Age
Subinvestigator for Human Papillomavirus Vaccine Study-Phase III for Gardisil 2006
Subinvestigator for APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Subinvestigator for An Open, randomized, Multi-Center Study of the Safety, Tolerability, and Immunogenicity of VAQTA Given Concomitantly with ProQuad and Prevnar in Healthy Children 12 Months of Age
Subinvestigator for An Expanded Phase 1/2a Randomized, Double-Blind, Placebo-
Controlled Study to Evaluate the Safety, Tolerability, Immunogenicity, and Viral Shedding of MEDI-560, A Live Attenuated Recombinant Parainfluenza Virus Type 3 (PIV3) Vaccine, Administered Intranasally to Healthy Infants 1 to < 12 Months of Age
Subinvestigator for A Phase 3, Open-Label, Randomized, Multi-Center Study to Evaluate the Safety and Immunogenicity of ProQuad Vaccine When Administered Concomitantly with Novartis Meningococcal ACWY Conjugate Vaccine to Healthy Toddlers
Subinvestigator for An Open-Label, Randomized, Multicenter Study of the Safety, Tolerability, and Immunogenicity of VAQTA Given Concomitantly With PedvaxHIB and Infanrix in Healthy Children Aged 15 Months of Age
Subinvestigator for A Phase 3, Open-Label Trial Evaluating the Safety, Tolerability, and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine in Healthy Children Aged 15 Months to 17 Years in the United States
Subinvestigator for A Randomized, Single-Blind, Placebo-Controlled, Phase 2 Trial of the Safety, Immunogenicity, and Tolerability of Meningococcal Serogroup B (MnB) rLP2086 Vaccine at Doses of 60 micrograms, 120 micrograms, and 200 micrograms in Healthy Adolescents Aged 11 to 18 Years
Subinvestigator for A Phase 3b, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine when Administered with Routine Infant Vaccinations to Healthy Infants
Subinvestigator for A Phase II, Randomized, Observer-Blind, Controlled, Multicenter Study to Assess Immunogenicity and Antibody Persistence Following Vaccination with GSK’s Candidate Combined Measles, Mumps, and Rubella Vaccine (MMR) Versus MMR II According to a One-Dose Schedule, Both Administered Subcutaneously at 12-15 Months of Age, Concomitantly with Hepatitis A Vaccine (HAV), Varicella Vaccine (VV), and Pneumococcal Conjugate Vaccine (PCV) but at Separate Sites
Subinvestigator for A Phase 3, Randomized, Active-Controlled, Double-Blind Trial Evaluating the Safety, Tolerability, and Immunogenicity of 3 Lots of 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants with Routine Pediatric Vaccinations in the United States
Subinvestigator for A Phase II, Randomized, Observer Blind, Multicenter Study of GlaxoSmithKline Biologicals’ Combined Measles-Mumps-Rubella-Varicella (MMRV) versus ProQuad, According to a One Dose Schedule, Both Administered Subcutaneously at 12-14 Months of Age, Concomitantly with Hepatitis A Vaccine (HAV) and Pneumococcal Conjugate Vaccine (PCV) but at Separate Sites
Subinvestigator for An Immunogenicity and Safety Evaluation of Two Doses of Menactra (Meningoccal Groups A, C, Y, and W-135 Polysaccharide Diptheris Toxoid Conjugate Vaccine) Given to Healthy Subjects at 9 and 12 Months of Age
Subinvestigator for An Open, Randomized, Multicenter Study of the Safety, Tolerability, and Immunogenicity of VAQTA Given Concomitantly With ProQuad and Prevnar in Healthy Children 12 Months of Age_
August 2007: Completed and certified in the CITI course in the Protection of Human Research Subjects
2003: Primary investigator and author of a study to determine the therapeutic effects of Osteopathic Manual Medicine on Pediatric Asthma Patients. This Study has been submitted to the IRB and returned with
recommendations. I am currently working with Dr Benjamin to incorporate his variability technology into this study for research.
2004 – present: Participating in ongoing research of Morgellons Disease which involves direct medical evaluation and treatment of patients, microscopic examination and evaluation of findings, forensic and laboratory testing. This work is in conjunction with Randy Wymore, PhD, and has included the Tulsa Police Department Forensics team. I authored a case definition of Morgellons Disease in 2006. In 2007 a Center for the Investigation of Morgellons Disease was designated as one of the Centers for Excellence. I was designated as the Lead Clinical Investigator for the center. The efforts of our research team contributed to the inclusion of Morgellons as entry number 4396 in the National Institute of Health’s Rare Disease list.
Continuing Medical Education
April 2003: Attended the OOA annual convention at Shangri La Resort
May 2003: Attended the OSU-CHS Annual Sports Medicine Medical Education Conference
September 2003: Attended the OEA conference in Chicago
November 2004: Attended the AOA and ACOP annual convention and Scientific Seminar in San Francisco
June 2005: Attended the Mississippi Osteopathic Medical Association Annual Medical Conference in Destin
October 2006: Attended the Fall AOA and ACOP Conference in Las Vegas in & sat for board re-certifiction
October 2007: Attended the Fall AOA and ACOP Convention and Scientific Seminar in San Diego
October 2008: Attended the Fall AOA and ACOP Convention and Scientific Seminar in Las Vegas
